Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2016

Sep 14, 2016

30786_dirs_2016-09-13_0a369c15-eaef-453c-8366-4b2a4da3740f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO RAD LABORATORIES INC (BIO, BIOB)
CIK: 0000012208
Period of Report: 2016-09-10

Reporting Person: SCHWARTZ NORMAN D (Director, Chairman, President, and CEO, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-09-10 Bio-Rad B Common Stock M 2000 Acquired 199763 Direct
2016-09-10 Bio-Rad B Common Stock F 1044 $159.80 Disposed 198719 Direct
2016-09-11 Bio-Rad B Common Stock M 5800 Acquired 204519 Direct
2016-09-11 Bio-Rad B Common Stock F 3027 $159.80 Disposed 201492 Direct
2016-09-12 Bio-Rad B Common Stock M 2617 Acquired 204109 Direct
2016-09-12 Bio-Rad B Common Stock F 1366 $159.32 Disposed 202743 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-09-10 Restricted Stock Units $0 M 2000 Disposed Bio-Rad B Common Stock (2000) Direct
2016-09-11 Restricted Stock Units $0 M 2600 Disposed Bio-Rad B Common Stock (2600) Direct
2016-09-11 Restricted Stock Units $0 M 3200 Disposed Bio-Rad B Common Stock (3200) Direct
2016-09-12 Restricted Stock Units $0 M 2617 Disposed Bio-Rad B Common Stock (2617) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Bio-Rad A Common Stock 411252 Direct
Bio-Rad B Common Stock 12586 Indirect
Bio-Rad B Common Stock 4060054 Indirect
Bio-Rad B Common Stock 13726 Indirect

Footnotes

F1: Shares of Class B common stock acquired on the vesting of restricted stock units.

F2: The reporting person disclaims beneficial ownership of these shares.

F3: The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

F4: The shares are held by a limited partnership of which the reporting person is a limited partner.

F5: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class B common stock.

F6: The restricted stock units vest in five equal annual installments beginning September 10, 2015.

F7: The restricted stock units vest in five equal annual installments beginning September 11, 2014.

F8: The restricted stock units vest in five equal annual installments beginning September 11, 2016.

F9: The restricted stock units vest in five equal annual installments beginning September 12, 2013.